multiple myeloma การใช้
- Today Velcade is an important drug in the treatment of multiple myeloma.
- He is an honorary board member of the Multiple Myeloma Research Foundation.
- Multiple myeloma is a type of cancer formed by malignant plasma cells.
- Daratumumab was given breakthrough therapy drug status in 2013 for multiple myeloma.
- He received a bone marrow transplant after being diagnosed with multiple myeloma.
- Stottlemyre was treated for multiple myeloma, or bone marrow cancer, in 2000.
- J . Karen Thomas was diagnosed with multiple myeloma in January 2015.
- Multiple myeloma can produce holes in many areas in bone, causing fractures.
- Velcade has shown great promise in treating patients with advanced multiple myeloma.
- The cause was multiple myeloma, a bone marrow cancer, his family said.
- They announced their partnership this week : the Multiple Myeloma Research Consortium.
- There is also an ongoing trial of this approach in multiple myeloma.
- He left that post in June 2012 to battle multiple myeloma.
- They diagnosed me in June, saying that I had multiple myeloma,
- Carfilzomib is also being evaluated in other stages of multiple myeloma.
- The cause of death was multiple myeloma, according to her daughter Margo Howard.
- Multiple myeloma is described both as a bone cancer and a blood cancer.
- The cause of death was multiple myeloma, a bone marrow cancer.
- The cause was multiple myeloma, said Eda Godel Hallinan, his companion.
- Multiple myeloma leads to death within five years for half of its victims.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3